UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$475M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$349M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$346M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$261M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.91B |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$1.28B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.17B |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$1.11B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$968M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.93% |
| 2 | Financials | 6.61% |
| 3 | Consumer Discretionary | 6.23% |
| 4 | Healthcare | 5.77% |
| 5 | Communication Services | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
Castle Biosciences
CSTL
$933M
| $748K | ﹤0.01% |
11,143
+7,121
| +177% | +$386K |
|
4252
Smith Micro Software
SMSI
$16.2M
| $748K | ﹤0.01% |
3,448
-21
| -0.6% | -$3.99K |
|
4253
Innovator S&P Investment Grade Preferred ETF
EPRF
$68.6M
| $747K | ﹤0.01% |
30,175
+26,675
| +762% | +$653K |
|
4254
Nuveen Global High Income Fund
JGH
$356M
| $747K | ﹤0.01% |
48,049
+3,630
| +8% | +$52.2K |
|
|
SRNE
4255
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $747K | ﹤0.01% |
109,465
+6,347
| +6% | +$51K |
|
4256
Abercrombie & Fitch
ANF
$4.84B
| $746K | ﹤0.01% |
36,617
-153,498
| -81% | -$2.81M |
|
|
HTLF
4257
DELISTED
Heartland Financial USA, Inc.
HTLF
| $745K | ﹤0.01% |
18,458
-31,455
| -63% | -$1.18M |
|
|
MZA
4258
DELISTED
BlackRock MuniYield Arizona Fund, Inc
MZA
| $745K | ﹤0.01% |
49,786
+8,217
| +20% | +$122K |
|
4259
PUT
Chemours
CC
$2.3B
| $744K | ﹤0.01% |
30,000
-150,000
| -83% | -$3.57M |
|
4260
Community Trust Bancorp
CTBI
$1.44B
| $744K | ﹤0.01% |
20,080
+2,000
| +11% | +$67.6K |
|
4261
SiTime
SITM
$20.7B
| $742K | ﹤0.01% |
6,631
+6,626
| +132,520% | +$627K |
|
|
CBAY
4262
DELISTED
Cymabay Therapeutics
CBAY
| $740K | ﹤0.01% |
128,944
+92,874
| +257% | +$703K |
|
4263
Fusion Fuel Green
HTOO
$17M
| $736K | ﹤0.01% |
+1,141
| New | +$733K |
|
4264
MINISO
MNSO
$3.53B
| $736K | ﹤0.01% |
+27,906
| New | +$603K |
|
|
TYG
4265
Tortoise Energy Infrastructure Corp
TYG
$1.1B
| $736K | ﹤0.01% |
36,621
-8,290
| -18% | -$151K |
|
4266
CALL
VICI Properties
VICI
$29B
| $734K | ﹤0.01% |
+28,800
| New | +$715K |
|
4267
AerCap
AER
$23.5B
| $732K | ﹤0.01% |
16,050
+3,450
| +27% | +$120K |
|
|
NAGE
4268
Niagen Bioscience
NAGE
$241M
| $731K | ﹤0.01% |
152,294
+1,694
| +1% | +$8.26K |
|
|
CLVS
4269
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $731K | ﹤0.01% |
152,200
+2,200
| +1% | +$11.1K |
|
4270
Compañía de Cervecerías Unidas
CCU
$2.16B
| $730K | ﹤0.01% |
49,607
+10,773
| +28% | +$147K |
|
4271
Invesco Food & Beverage ETF
PBJ
$109M
| $729K | ﹤0.01% |
20,322
-722
| -3% | -$24.8K |
|
|
DMC
4272
Del Monte Corp
DMC
$1.44B
| $728K | ﹤0.01% |
30,260
-345
| -1% | -$8.32K |
|
4273
Invesco S&P 100 Equal Weight ETF
EQWL
$2.81B
| $727K | ﹤0.01% |
10,609
-3,077
| -22% | -$198K |
|
4274
Axsome Therapeutics
AXSM
$11.2B
| $726K | ﹤0.01% |
8,914
-4,539
| -34% | -$339K |
|
4275
Scansource
SCSC
$1.06B
| $726K | ﹤0.01% |
27,527
+3,450
| +14% | +$82.8K |
|
Similar funds
UBS Group's Q4 2020 Portfolio in Review
As of Q4 2020, UBS Group held 9,236 positions worth $296B, up 11% from $265B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q4 2020 filing shows 1,125 new, 3,976 increased, 2,989 reduced and 738 closed positions. Its largest new stake was Vontier: 502,899 shares worth $16.8M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.91B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
- UBS Group's largest Q4 2020 buy was Vontier: 502,899 shares worth $16.8M.
- UBS Group added most to UBS Group in Q4 2020, an estimated $475M increase.
- UBS Group's biggest Q4 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.91B.
- UBS Group fully exited Delphi Technologies PLC Ordinary Shares in Q4 2020, selling an estimated $96.7M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q4 2020.
- UBS Group opened 1,125 new positions and closed 738 in Q4 2020.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.